 Analysts predict that Corbus Pharmaceuticals Holdings Inc NASDAQ:CRBP will report sales of 3.90 million for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for Corbus Pharmaceuticals earnings, with the lowest sales estimate coming in at 1.76 million and the highest estimate coming in at 9.25 million. Corbus Pharmaceuticals posted sales of ... 